STAT5B and acute lymphoblastic leukemia: We confirmed the dependence of T-ALL cells on STAT5B and ZAP70 in a CRISPR/Cas9 genetic knockout experiment and found that STAT5 or SYK inhibitors effectively blocked growth and survival of T-ALL cell lines, more than CD3+ T cells from healthy donors.